Startseite
Reels
Gruppen
Seiten
Mehr sehen
Gruppen Seiten Meine Blogs Meine Angebote Meine Jobs Meine Kurse Veranstaltungen Blogs Angebote Jobs Kurse Foren Filme Spiele
Anmelden Registrieren
Tagesmodus
TUDRIQEV Approval for Advanced Melanoma: Regulatory Progress, Mechanism, and Clinical Outlook
Replimune has reached an important milestone in oncology with the FDA’s accelerated approval of tudriqev (vusolimogene oderparepvec-wtpg), previously identified as RP1, in combination with Bristol Myers Squibb’s OPDIVO (nivolumab). Granted on August 6, 2026, the approval applies to adults with unresectable, advanced cutaneous melanoma that has progressed after treatment with an...
0 Kommentare ·0 Geteilt ·197 Ansichten ·0 Bewertungen
Bitte melde dich an, um zu liken, zu teilen und zu kommentieren!
Villagge https://villagge.com